期刊文献+

奥氮平与利培酮对青少年精神分裂症首发患者糖、脂代谢的影响对照研究 被引量:8

Changes of bolod glucose and lipid levels in adolescents with first-episode schizophrenia treated with olanzapine and riperidone
下载PDF
导出
摘要 目的探讨奥氮平与利培酮对首发青少年精神分裂症患者空腹血糖及血脂水平的影响。方法70例符合入组标准的精神分裂症患者被随机分为奥氮平组(32例)和利培酮组(38例)。治疗观察6周。两组患者在治疗前及治疗第6周末分别检测空腹血糖、总胆固醇、甘油三脂、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、身高、体质量并计算体质量指数。结果(1)治疗第6周末,奥氮平组患者的体质量指数、血糖、甘油三脂及低密度脂蛋白胆固醇水平均升高,与治疗前的差异有统计学意义(P<0.05);两组患者的体质量指数差值、血糖差值及甘油三脂差值间比较有统计学意义(P<0.05)。(2)两组患者男女间各项指标差值的比较均无统计学意义(P>0.05)。(3)奥氮平组患者体质量的增加与血糖、甘油三脂有显著相关关系(P<0.05)。结论奥氮平对青少年精神分裂症患者糖、脂代谢的影响明显大于利培酮。 Objective To assess the effects of olanzapine and risperldone on blood glucose and lipid levels in adolescents with first-episode schizophrenia. Methods Seventy adolescents with first-episode schizophrenia were randomly assigned into olanzapine group(32 cases) and risperidone group(38 cases). Planed assessments included fasting blood glucose(FBS), total cholestral (TC), triglyceride(TG), high density lipoprotein-cholesterol(HDL), low density lipoprotein-cholesterol(LDL)and the body mass index(BMI), which were collected at baseline and the end of the 6-week period. Results After 6-week treatment,the levels of FBS, BMI, TG and LDL in olanzapine group were significanlty higher than those before treatment(P〈0.05). Olanzaping group showed a significant increase of FBS, BIM and TG levels at the end of the 6-week period than risperidone group (P〈0.05). In each group, changes of above-mentioned variants were showed no significant differences between male and female(P〉0.05). Weight gain at endpoint was significantly related to the changes of FBS and TG in the olanzapine group(P〈0.05). Conclusion Olanzapine has more severe side-effects on the glucose metabolism and lipid metabolism than risperidone.
作者 李敏 解昌国
出处 《精神医学杂志》 2008年第2期107-109,共3页 Journal of Psychiatry
关键词 奥氮平 利培酮 青少年 精神分裂症 血糖 血脂 Olanzapine Risperidone Adolescent Schizophrenia Blood glucose Blood lipid
  • 相关文献

参考文献7

  • 1[1]Sernyak MJ,Leslie DL,Alarcon BD,et al.A,ssociation of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia[J].Am J Psychiatry,2002,159(4):561-566 被引量:1
  • 2[2]Lindenmayer JP,Czobor P,Volavka J,et al.Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics[J].Am J Psychiatry,2003,160(2)1290-296 被引量:1
  • 3[3]Wirshing DA,Spdlberg BJ.Erhart SM,et al.Novel antipsychotics and new onset diabetes[J].Biol Psychiatry,1998,44(8):778-783 被引量:1
  • 4刘素芳,魏平,王世贵,王东平,王云,马慧娟,贾福军.不同剂量氯氮平与精神分裂症患者血脂、血糖代谢的对照研究[J].中华精神科杂志,2005,38(2):82-85. 被引量:31
  • 5吴仁容,赵靖平.四种抗精神病药对糖代谢及脂代谢的不良影响[J].中华精神科杂志,2005,38(3):130-133. 被引量:83
  • 6[6]Melkersson KI.Hulting AL,Brismar KE.Elevated levels of insulin,leptin.and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses[J].J Clin Psychiary,2000,61(10):742-749 被引量:1
  • 7[7]Bushe C,Paton C.The potential impact of antipsychotics on lipids in schizophrenia:is there enough evidence to con-form a link[J].Psychophamacology(Berl),2005,19(6)Suppl:76-83 被引量:1

二级参考文献11

共引文献110

同被引文献107

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部